Newsfeeds Archive - Spark Newswire

3 minute read

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

November 28, 3:44 PM

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

ALLG

2 minute read

Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today?

By Vandana Singh

November 28, 12:19 PM

Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in

FTRE

2 minute read

Analyst Ratings

What 5 Analyst Ratings Have To Say About Acelyrin

By Benzinga Insights

November 28, 9:00 AM

Within the last quarter, Acelyrin (NASDAQ:SLRN) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

SLRN

25 minute read

Earnings

Earnings Scheduled For November 7, 2023

By Benzinga Insights

November 7, 7:34 AM

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

ABUS

22 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

October 4, 12:01 PM

On Wednesday, 311 stocks hit new 52-week lows.

AADI

28 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 21, 12:08 PM

During the session on Thursday, 461 stocks hit new 52-week lows.

$TKO

3 minute read

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

September 13, 2:07 PM

Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.

AAOI

13 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 13, 2023

By Benzinga Insights

September 13, 11:00 AM

Upgrades For Southern Co (NYSE:SO), B of A Securities upgraded the previous rating of Underperform to Neutral. For…

$TKO

1 minute read

Despite Trial Setback For Acelyrin’s Lead Program, Analyst Shows Optimism

By Vandana Singh

September 12, 2:57 PM

Acelyrin Inc (NASDAQ: SLRN) announced topline results from Part B of a Phase 2b/3 trial evaluating izokibep for moderate-to-severe Hidradenitis Suppurativa (HS).

SLRN

3 minute read

Crude Oil Rises 2%; Avalo Therapeutics Shares Spike Higher

By Lisa Levin

September 12, 2:44 PM

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Tuesday. The Dow traded up 0.11% to 34,702.55 while the NASDAQ fell 0.86% to 13,797.73. The S&P 500, also fell, dropping, 0.42% to 4,468.82.

AVTX